Grants and Contributions:

Back to search

Title:

Development of a novel oral probiotic and microencapsulation technology

Agreement Number:

914176

Agreement Value:

$178,300.00

Agreement Date:

Sep 1, 2018 - May 31, 2019

Description:

DoseBiome is changing how we eat to better serve the microbes that live within us! We’re an oral microbiome company that’s already developed a patented beverage that targets the microbes in your mouth. Our first product, qii, is a tea-based drink that actively targets bacteria that causes cavities, gingivitis and bad breath. It’s on-the-go health so you can stay clean anywhere, anytime. DoseBiome plans to expand the qii lineup with proprietary oral probiotics that will be developed through this IRAP project. This will be a probiotic water that can help re-colonize your mouth with healthy bacteria. This product will the first of its kind – addressing both oral health (probiotics) and also shelf stability in water (microencapsulation).

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Toronto, Ontario, CA M5G 0B7

Reference Number:

172-2018-2019-Q4-914176

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

841318108

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The total amended value is 178,300 dollars.

Amendment Date

Mar 1, 2019

Recipient's Legal Name:

DoseBiome Inc.

Federal Riding Name:

University--Rosedale

Federal Riding Number:

35110

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

541710

Amendments:

See Amendments